TeselaGen Biotechnology
PrivateLast Round
Accelerator
Sep 20, 2023
Total Funding Raised
$3.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TeselaGen Biotechnology operates in Enterprise Software and is based in Portola Valley, California. Its latest recorded funding round was an Accelerator round in September 2023.
TeselaGen Biotechnology is a biotechnology and enterprise software company that provides an AI-powered platform to accelerate product development for therapeutics, chemicals, and agricultural products.
Sector
Enterprise Software
Verticals
Biotechnology, Drug Discovery, Workflow Automation, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TeselaGen Biotechnology Comparables
Compare TeselaGen Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scispot | 83% | |
| Synthace | 81% | |
| Cenevo | 78% |
For institutional investors. Book with your work email.
TeselaGen Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 20, 2023 | ||||
| Seed | Oct 14, 2020 | ||||
| Seed | Jan 18, 2018 | ||||
| Grant | Feb 7, 2017 | ||||
| Grant | Oct 1, 2014 | ||||
Angel | May 4, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TeselaGen Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taram Capital | Seed |
| Propel(x) | Seed |
| WeBoost VC | Seed |
| Baruch Future Ventures | Angel |
| National Science Foundation | Grant, Seed |
| Endeavor Miami | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 86% MoM, reaching 7.2K.
- Apr 28, 2026
Added Alexmulder, an enterprise customer in Academia/Research.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 12, 2026
TeselaGen Biotechnology, Inc. and bitBiome, Inc. collaborate to connect AI-driven microbial discovery with laboratory experiments, with bitBiome, Inc. deploying TeselaGen Biotechnology, Inc.'s platform for strain engineering, sample tracking and automated workflows on Nov 12th '26 in California and Japan.
- partners_withOct 29, 2026
TeselaGen Biotechnology, Inc. and TEC announce a multi-year collaboration in California on Oct 29th '26 to accelerate scientific discovery through advanced biological design tools and artificial intelligence.
For institutional investors. Book with your work email.
TeselaGen Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TeselaGen Biotechnology's valuation, stock price, and market status.
Is TeselaGen Biotechnology a public or private company?
TeselaGen Biotechnology is a private company.
What is the current stock price of TeselaGen Biotechnology?
TeselaGen Biotechnology is a private company, so its shares have no public market price. Caplight tracks TeselaGen Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TeselaGen Biotechnology worth (valuation)?
Valuation information for TeselaGen Biotechnology is not publicly available.
Can I buy TeselaGen Biotechnology stock?
TeselaGen Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TeselaGen Biotechnology's last funding round?
TeselaGen Biotechnology's most recent funding round was Accelerator on September 20, 2023.
Who are the main investors in TeselaGen Biotechnology?
Key investors in TeselaGen Biotechnology include Taram Capital, Propel(x), WeBoost VC, Baruch Future Ventures, National Science Foundation.
Will TeselaGen Biotechnology IPO soon?
No public IPO plans have been announced for TeselaGen Biotechnology.
How can I track TeselaGen Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in TeselaGen Biotechnology's shares on secondary markets.